Technical Analysis for BIAF - bioAffinity Technologies, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| D | 2.07 | -0.48% | -0.01 |
BIAF closed down 0.48 percent on Wednesday, May 8, 2024, on 15 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
Earnings due: May 13
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| NR7 | Range Contraction | 0.00% | |
| NR7-2 | Range Contraction | 0.00% | |
| Narrow Range Bar | Range Contraction | 0.00% | |
| Lower Bollinger Band Walk | Weakness | 0.00% | |
| Inside Day | Range Contraction | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| Bullish Engulfing | Bullish | -0.48% | |
| NR7 | Range Contraction | -0.48% | |
| Lower Bollinger Band Walk | Weakness | -0.48% |
| Alert | Time |
|---|---|
| Up 1% | about 13 hours ago |
| Possible NR7 | about 13 hours ago |
| Possible Inside Day | about 13 hours ago |
| 60 Minute Opening Range Breakout | about 14 hours ago |
| Down 3% | about 16 hours ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/13/2024
bioAffinity Technologies, Inc., a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat cancer at the cellular level. The company was founded in 2014 and is based in San Antonio, Texas.
Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Biotechnology Cancer Life Sciences Biology Diagnostic Tests Lung Cancer Molecular Diagnostics Cancer Therapeutics
Classification
Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Biotechnology Cancer Life Sciences Biology Diagnostic Tests Lung Cancer Molecular Diagnostics Cancer Therapeutics
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 3.62 |
| 52 Week Low | 0.9548 |
| Average Volume | 291,799 |
| 200-Day Moving Average | 1.72 |
| 50-Day Moving Average | 2.28 |
| 20-Day Moving Average | 2.48 |
| 10-Day Moving Average | 2.27 |
| Average True Range | 0.26 |
| RSI (14) | 41.18 |
| ADX | 24.15 |
| +DI | 19.82 |
| -DI | 20.64 |
| Chandelier Exit (Long, 3 ATRs) | 2.38 |
| Chandelier Exit (Short, 3 ATRs) | 2.71 |
| Upper Bollinger Bands | 3.06 |
| Lower Bollinger Band | 1.90 |
| Percent B (%b) | 0.15 |
| BandWidth | 46.87 |
| MACD Line | -0.06 |
| MACD Signal Line | 0.03 |
| MACD Histogram | -0.0861 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 2.24 | ||||
| Resistance 3 (R3) | 2.23 | 2.17 | 2.21 | ||
| Resistance 2 (R2) | 2.17 | 2.12 | 2.17 | 2.20 | |
| Resistance 1 (R1) | 2.12 | 2.10 | 2.14 | 2.13 | 2.19 |
| Pivot Point | 2.05 | 2.05 | 2.07 | 2.06 | 2.05 |
| Support 1 (S1) | 2.01 | 2.01 | 2.03 | 2.01 | 1.95 |
| Support 2 (S2) | 1.94 | 1.98 | 1.95 | 1.94 | |
| Support 3 (S3) | 1.89 | 1.94 | 1.93 | ||
| Support 4 (S4) | 1.90 |
